
  Mrv0541 09241312492D          

  8  7  0  0  0  0            999 V2000
    0.7145    0.9281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289   -0.3094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -0.3094    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.0000   -1.1344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7145    0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4289   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0  0  0  0
  3  2  1  0  0  0  0
  4  2  1  0  0  0  0
  4  5  1  1  0  0  0
  6  4  1  0  0  0  0
  7  6  1  0  0  0  0
  8  6  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB00161

> <DRUG_GROUPS>
approved; nutraceutical

> <GENERIC_NAME>
L-Valine

> <SYNONYMS>
(2S)-2-Amino-3-methylbutanoic acid; (S)-Valine; 2-Amino-3-methylbutyric acid; L-(+)-alpha-Aminoisovaleric acid; L-alpha-Amino-beta-methylbutyric acid; Val; Valine

> <CHEMICAL_FORMULA>
C5H11NO2

> <MOLECULAR_WEIGHT>
117.1463

> <EXACT_MASS>
117.078978601

> <IUPAC_NAME>
(2S)-2-amino-3-methylbutanoic acid

> <IUPAC_TRADITIONAL_NAME>
L-valine

> <INCHI_IDENTIFIER>
InChI=1/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/s2

> <INCHI_KEY>
InChIKey=KZSNJWFQEVHDMF-SGAVLPGINA-N

> <SMILES>
CC(C)[C@H](N)C(O)=O

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_ACIDIC_PKA>
2.72

> <JCHEM_BASIC_PKA>
9.6

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-2.3

> <JCHEM_LOGP>
-2

> <ALOGPS_LOGS>
0.26

> <JCHEM_POLARIZABILITY>
12.19

> <JCHEM_POLAR_SURFACE_AREA>
63.32

> <JCHEM_REFRACTIVITY>
29.49

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <ALOGPS_SOLUBILITY>
2.14e+02 g/l __ 

$$$$
